Skip to main content

Table 2 Average time spent per case in function of the method and the participant

From: Timeline representation of clinical data: usability and added value for pharmacovigilance

Method Participant

Usual

Timeline

Difference

P-value

Participant 1

17′ 26″

11′ 38″

- 5′ 48″

0.02

Participant 2

15′ 55″

18′ 11″

+  2′ 16″

0.71

Participant 3

16′ 8″

17′ 40″

+ 1′ 32″

0.59